Make Trial Participation a Condition of Coverage for Certain New Drugs, Say Experts

The Centers for Medicare and Medicaid Services (CMS) should require clinical trial participation of patients seeking coverage for many new drugs, particularly those that have accelerated approval.
Source: Drug Industry Daily